Specification of Analysis

Description

AOD9604 is a peptide (a chain of amino acids) which was developed and patented by a company called Metabolic Pharmaceuticals in Australia in the late 1990s. AOD stands for "Anti Obesity Dru g". This peptide has an amino acid sequence that mimics the lipolytic region of g-h (the region of this hormones thought to be responsible for burning fat) and it has been promoted variously as a weight loss supplement, as an aid to muscle and cartilage repair, and a treatment for osteoarthritis by its manufacturers. It is also known as lipotropin and Tyr-g-h fragment, and is generally available these days as a transdermal cream or an injectable.

Function 

1. Reduces the most stubborn abdominal fat;
2. Maintains muscle mass;
3. Improve bone density fragility in Osteoporosis;
4. Accelerate soft tissue damage from injury;
5. Increases I F-1 levels, in an effective manner, thus making this a peptide that burns fat;
6. Increases energy expenditure;
7. Imporoves lipid profiles and lipolytic activity, does not negatively impact blood glucose levels, nor does cell proliferation occur, like g-h;
8. Extremely potent and effective fat burner

Application 

AOD9604 can be injected or taken orally. The amount is 500mcg per bodyweight for 19 days. However, some sites do not know the exact amount of drug some people have taken because only a small amount has been used in scientific studies.